Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials
This study represents an integrated analysis of 2 previous clinical trials: GOBI (ClinicalTrials.gov, NCT04139798) and MOJAVE (ClinicalTrials.gov, NCT04567329).
Authors
- Jason L. Vittitow
- Sonja Krösser
- Joseph Tauber (ORCID: https://orcid.org/0000-0001-5365-8795)
- Ahmad Fahmy
- Jack V. Greiner (ORCID: https://orcid.org/0000-0003-1659-1020)
- Jennifer Harthan (ORCID: https://orcid.org/0000-0002-1963-7816)
- John D. Sheppard (ORCID: https://orcid.org/0000-0003-1216-4056)
- David G. Evans (ORCID: https://orcid.org/0000-0002-8685-671X)
Institutions
- Novaliq (Germany) (DE)
- Bausch Health (United States) (US)
- Total (United States) (US)
- Minnesota Eye Consultants (US)
- Massachusetts Eye Research and Surgery Institute (US)
- Virginia Eye Consultants (US)
- Tauber Eye Center (US)
- Illinois College of Optometry (US)
Publication Details
- Journal
- Frontiers in Ophthalmology
- Published
- 2024-11-05
- DOI
- https://doi.org/10.3389/fopht.2024.1452422
- Citations
- 5
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 2.71